Výsledky vyhledávání - "Rudolf Schwarz"

Akademický článek

Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry

Autor: Danny Jazmati, Barbara Hero, Theresa M. Thole.-Kliesch, Julien Merta, Hedwig E. Deubzer, Christian Bäumer, Feline Heinzelmann, Stefanie Schulze Schleithoff, Friederike Koerber, Angelika Eggert, Rudolf Schwarz, Thorsten Simon, Beate Timmermann

Publikováno v: Current Oncology, Vol 29, Iss 11, Pp 8222-8234 (2022)

Background: Despite an intensive multimodal treatment approach, approximately 50% of high-risk (HR) neuroblastoma (NB) patients experience progression. Despite the advances in targeted therapy, high-dose chemotherapy, and other systemic treatment opt

Externí odkaz: https://doaj.org/article/2eda78254f904a3a9f743eb2d70d7c1b

Zobrazit plný text záznamu

Akademický článek

Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry

Publikováno v: Frontiers in Oncology, Vol 10 (2021)

ObjectiveRadiotherapy (RT) is an integral part of the interdisciplinary treatment of patients with high-risk neuroblastoma (NB). With the continuous improvements of outcome, the interest in local treatment strategies that reduce treatment-related sid

Externí odkaz: https://doaj.org/article/b7b0dbc652e440648be656c043c9eca4

Zobrazit plný text záznamu

Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study

Autor: Roger E. G. Schutgens, Annie Borel Derlon, Sohan Dey, Barbara Faganel Kotnik, Olga Katsarou, Carmen Escuriola Ettingshausen, Irina Matytsina, Paula F. Ypma, Rudolf Schwarz

Publikováno v: Haemophilia. 28:46-54

Introduction Turoctocog alfa (NovoEight® ) is a B-domain-truncated recombinant factor VIII (FVIII) approved for patients with haemophilia A. Aim To investigate the long-term safety and efficacy of turoctocog alfa in routine clinical practice. Method

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2234e03b4a541b4524ce3793e697b973
https://doi.org/10.1111/hae.14454

Zobrazit plný text záznamu

QUARTET:A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer

Publikováno v: Kelly, S M, Effeney, R, Gaze, M N, Bernier-Chastagner, V, Blondeel, A, Clementel, E, Corning, C, Dieckmann, K, Essiaf, S, Gandola, L, Janssens, G O, Kearns, P R, Lacombe, D, Lassen-Ramshad, Y, Merks, H, Miles, E, Padovani, L, Scarzello, G, Schwarz, R, Timmermann, B, van Rijn, R R, Vassal, G, Boterberg, T, Mandeville, H C & the QUARTET Project and the SIOPE Radiation Oncology Working Group 2022, ' QUARTET : A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer ', European Journal of Cancer, vol. 172, pp. 209-220 . https://doi.org/10.1016/j.ejca.2022.05.037
the QUARTET Project and the SIOPE Radiation Oncology Working Group 2022, ' QUARTET : A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer ', European Journal of Cancer, vol. 172, pp. 209-220 . https://doi.org/10.1016/j.ejca.2022.05.037
European Journal of Cancer, 172, 209-220. Pergamon
EUROPEAN JOURNAL OF CANCER

The European Society for Paediatric Oncology (SIOPE) Radiation Oncology Working Group presents the QUARTET Project: a centralised quality assurance programme designed to standardise care and improve the quality of radiotherapy and imaging for inter-n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c44076608e600da9d46435dfc286361
https://pure.au.dk/portal/da/publications/quartet(977caf64-1003-49f2-90f8-7be5415ad60b).html

Zobrazit plný text záznamu

Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial

Publikováno v: Dietzsch, Stefan; Braesigk, Annett; Seidel, Clemens; Remmele, Julia; Kitzing, Ralf; Schlender, Tina; Mynarek, Martin; Geismar, Dirk; Jablonska, Karolina; Schwarz, Rudolf; Pazos, Montserrat; Weber, Damien C; Frick, Silke; Gurtner, Kristin; Matuschek, Christiane; Harrabi, Semi Ben; Glück, Albrecht; Lewitzki, Victor; Dieckmann, Karin; Benesch, Martin; ... (2022). Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial. Strahlentherapie und Onkologie, 198(3), pp. 282-290. Springer 10.1007/s00066-021-01822-0

Purpose In Germany, Austria, and Switzerland, pretreatment radiotherapy quality control (RT-QC) for tumor bed boost (TB) in non-metastatic medulloblastoma (MB) was not mandatory but was recommended for patients enrolled in the SIOP PNET5 MB trial bet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec05ed80efa86ba88d72436065cf52cb
https://doi.org/10.1007/s00066-021-01822-0

Zobrazit plný text záznamu

Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of Recurrence

Autor: Markus Graefen, Sophie Knipper, Rudolf Schwarz, Hartwig Huland, Guido Sauter, Thomas Steuber, Tobias Maurer, Lars Budäus, Hans Heinzer, Derya Tilki, Katharina Boehm, Philipp Mandel, Maryam Sadat-Khonsari

Publikováno v: Clinical Genitourinary Cancer. 18:e112-e121

The purpose of this study was to investigate adherence to recommended adjuvant radiotherapy (aRT) in radical prostatectomy (RP) patients with adverse pathologic features and to analyse the outcome of patients who followed or denied this recommendatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3471962f5353b6d8c084686946e7b0db
https://doi.org/10.1016/j.clgc.2019.09.007

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání